Codexis (CDXS) Cash from Investing Activities Growth (5y) (2015 - 2026)
Codexis (CDXS) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Codexis |
213.30 Mn |
148.16 Mn |
13.18 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
15.20% |
| Dec 31, 2025 |
33.85% |
| Sep 30, 2025 |
59.41% |
| Jun 30, 2025 |
26.65% |
| Mar 31, 2025 |
77.19% |
| Dec 31, 2024 |
-47.22% |
| Sep 30, 2024 |
22.59% |
| Jun 30, 2024 |
-101.67% |
| Mar 31, 2024 |
-129.87% |
| Dec 31, 2023 |
29.15% |
| Sep 30, 2023 |
-12.99% |
| Jun 30, 2023 |
-1.53% |
| Mar 31, 2023 |
-190.04% |
| Dec 31, 2022 |
16.38% |
| Sep 30, 2022 |
-84.64% |
| Jun 30, 2022 |
-38.16% |
| Mar 31, 2022 |
-111.90% |
| Dec 31, 2021 |
-123.62% |
| Sep 30, 2021 |
-105.37% |
| Jun 30, 2021 |
-63.10% |
